Martin Felices

Person

Minneapolis, MN, US

People

Patents Applicationslast 30 patents

Information Patent Application
NK CELL ENGAGER MOLECULES AND METHODS OF USE
- Publication number 20240317831
- Publication date Sep 26, 2024
- Regents of the University of Minnesota
- Martin Felices
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED ADAM17 BLOCKER COMPOUNDS, ANTI-ADAM17 ANTIBODIES, METHODS...
- Publication number 20240279351
- Publication date Aug 22, 2024
- Regents of the University of Minnesota
- Bruce Walcheck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CLEC12A ANTIBODY FRAGMENT SEQUENCES AND METHODS
- Publication number 20240117053
- Publication date Apr 11, 2024
- Regents of the University of Minnesota
- Martin Felices
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
B7H3-TARGETING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20230203166
- Publication date Jun 29, 2023
- Regents of the University of Minnesota
- Martin Felices
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE
- Publication number 20220363737
- Publication date Nov 17, 2022
- Regents of the University of Minnesota
- Jeffrey S. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY COMPOUNDS AND METHODS
- Publication number 20220324972
- Publication date Oct 13, 2022
- Regents of the University of Minnesota
- Daniel A. VALLERA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NK ENGAGER MOLECULES AND METHODS OF USE THEREOF
- Publication number 20210388093
- Publication date Dec 16, 2021
- Regents of the University of Minnesota
- Jeffrey S. Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Martin Felices

Person

Patents Applicationslast 30 patents

NK CELL ENGAGER MOLECULES AND METHODS OF USE

TARGETED ADAM17 BLOCKER COMPOUNDS, ANTI-ADAM17 ANTIBODIES, METHODS...

CLEC12A ANTIBODY FRAGMENT SEQUENCES AND METHODS

B7H3-TARGETING PROTEINS AND METHODS OF USE THEREOF

NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE

IMMUNOTHERAPY COMPOUNDS AND METHODS

NK ENGAGER MOLECULES AND METHODS OF USE THEREOF